Pentazocine

Pentazocine

SCHEMBL7865847

CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C.O=C(O)C(O)C(O)C(=O)O

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

SIGMAR1

The experimentally established mechanism targets of Pentazocine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SIGMAR1 known ✓ Q99720 10/20 0.83
OPRM1 P35372 6/20 0.83
OPRD1 P41143 4/20 0.83
OPRK1 P41145 4/20 0.83
TMEM97 Q5BJF2 4/20 0.83
EBP Q15125 2/20 0.83
CYP1A2 P05177 1/20 0.66
CYP3A4 P08684 1/20 0.66
CYP2D6 P10635 1/20 0.66
TSHR P16473 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(+)-Pentazocine SCHEMBL42094 0.94 SIGMAR1 (0.83) SIGMAR1OPRM1OPRD1OPRK1TMEM97
(+)-Pentazocine SCHEMBL3665045 0.94 SIGMAR1 (0.83) SIGMAR1OPRM1OPRD1OPRK1TMEM97
Pentazocine SCHEMBL16107180 0.94 SIGMAR1 (0.83) SIGMAR1OPRM1OPRD1OPRK1TMEM97
Rel-Pentazocine SCHEMBL135685 0.91 SIGMAR1 (1.00) SIGMAR1OPRM1OPRD1OPRK1TMEM97
(+)-Pentazocine SCHEMBL680675 0.91 SIGMAR1 (1.00) SIGMAR1OPRM1OPRD1OPRK1TMEM97
Pentazocine SCHEMBL2493 0.91 SIGMAR1 (1.00) SIGMAR1OPRM1OPRD1OPRK1TMEM97
(+)-Pentazocine SCHEMBL4376337 0.91 SIGMAR1 (1.00) SIGMAR1OPRM1OPRD1OPRK1TMEM97
(+)-Pentazocine SCHEMBL16220021 0.91 SIGMAR1 (1.00) SIGMAR1OPRM1OPRD1OPRK1TMEM97
(+)-Pentazocine SCHEMBL22865258 0.91 SIGMAR1 (1.00) SIGMAR1OPRM1OPRD1OPRK1TMEM97
(+)-Pentazocine SCHEMBL18672553 0.91 SIGMAR1 (1.00) SIGMAR1OPRM1OPRD1OPRK1TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0782861-B1 DRUG COMPOUNDING INGREDIENTS COMPRISING N-SUBSTITUTED-O-TOLUIDINE DERIVATIVE AND PERCUTANEOUSLY ABSORBABLE PREPARATION HISAMITSU PHARMACEUTICAL CO (JP) 2001-12-12 EP disclosed
US-5891920-A Medicinal adjuvants consisting of N-subsitituted-o-toluidine derivatives, and percutaneously absorbable preparations comprising the adjuvants HISAMITSU PHARMACEUTICAL CO., INC. (JP) 1999-04-06 US disclosed
EP-0782861-A1 DRUG COMPOUNDING INGREDIENTS COMPRISING N-SUBSTITUTED-O-TOLUIDINE DERIVATIVE AND PERCUTANEOUSLY ABSORBABLE PREPARATION Hisamitsu Pharmaceutical Co., Inc. (JP) 1997-07-09 EP disclosed